References
- Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012;30:1–22.
- Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767–811.
- Guermonprez P, Valladeau J, Zitvogel L, et al. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002;20:621–667.
- Oyaizu H, Adachi Y, Yasumizu R, et al. Protection of T cells from radiation-induced apoptosis by cepharanthine. Int Immunopharmacol 2001;1:2091–2099.
- Morikawa K, Oseko F, Morikawa S. Inhibition of proliferation and differentiation of human B-lymphocytes by a biscoclaurine alkaloid. Int J Immunopharmacol 1992;14:941–949.
- Uto T, Nishi Y, Toyama T, et al. Inhibitory effect of cepharanthine on dendritic cell activation and function. Int Immunopharmacol 2011;11:1932–1938.
- Hua P, Sun M, Zhang G, et al. Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells. Biochem Biophys Res Commun 2015;460:136–142.
- Biswas KK, Tancharoen S, Sarker KP, et al. Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt. FEBS Lett 2006;580:703–710.
- Wu J, Suzuki H, Zhou YW, et al. Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines. J Cell Biochem 2001;82:200–214.
- Takahashi-Makise N, Suzu S, Hiyoshi M, et al. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway. Int J Cancer 2009;125:1464–1472.
- Uto T, Wang X, Sato K, et al. Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 2007;178:2979–2986.
- Furusawa S, Wu J, Fujimura T, et al. Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis. Methods Find Exp Clin Pharmacol 1998;20:87–97.
- Kikukawa Y, Okuno Y, Tatetsu H, et al. Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid. Int J Oncol 2008;33:807–814.
- McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013;5:a008656.
- Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007;449:419–426.
- Corthay A. A three-cell model for activation of naïve T helper cells. Scand J Immunol 2006;64:93–96.
- Gaurav R, Agrawal DK. Clinical view on the importance of dendritic cells in asthma. Expert Rev Clin Immunol 2013;9:899–919.
- Barton GM, Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 2002;14:380–383.
- Hirota K, Duarte JH, Veldhoen M, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 2011;12:255–263.
- Weir CR, Nicolson K, Bäckström BT. Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide. Immunol Cell Biol 2002;80:14–20.
- Pöhlmann S, Soilleux EJ, Baribaud F, et al. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci USA 2001;98:2670–2675.
- Popov S, Chenine AL, Gruber A, et al. Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells. J Virol 2005;79:602–608.